O'Sullivan Gabrielle M, Philips Joshua G, Mitchell Heidi J, Dornbusch Michael, Rasko John E J
Research Ethics and Governance Office, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW, Australia.
Office of the Gene Technology Regulator, Australian Government Department of Health, Canberra, ACT, Australia.
Front Med (Lausanne). 2022 May 10;9:883434. doi: 10.3389/fmed.2022.883434. eCollection 2022.
•In contrast to the prior voluntary system, since 2001, gene technology in Australia has been regulated under a legislated national Gene Technology Regulatory Scheme which is administered by the Gene Technology Regulator.•The Scheme provides science-based assessment of the potential risks of gene technology to the health and safety of people and the environment.•It complements the role of the Australian Therapeutic Goods Administration which regulates all therapeutic products in Australia to ensure they are safe and effective.•Recent reforms to the Scheme contribute to, and anticipate, the continued safe development and delivery of gene-based human therapeutics in Australia as a successful model for other jurisdictions.
与先前的自愿制度不同,自2001年以来,澳大利亚的基因技术一直依据一项由基因技术监管机构管理的法定国家基因技术监管计划进行监管。
该计划对基因技术给人类健康和安全以及环境带来的潜在风险进行基于科学的评估。
它补充了澳大利亚治疗用品管理局的作用,该局对澳大利亚所有治疗产品进行监管,以确保其安全有效。
该计划最近的改革有助于并预期澳大利亚将继续安全地开发和提供基于基因的人类治疗方法,成为其他司法管辖区的成功典范。